Pharmaceutical major Dr. Reddy’s Laboratories has announced the first-to-market launch of Naproxen and Esomeprazole Magnesium delayed release tablets, a therapeutic equivalent of generic version of Vimovo (Naproxen and Esomeprazole Magnesium) delayed release tablets approved by the US Food and Drug Administration.
Dr. Reddy’s Naproxen and Esomeprazole Magnesium delayed release tablets will be available in 375mg/20mg and 500mg/20mg tablets in bottle count sizes of 60.
The launch, according to the company’s North America Generics chief executive officer Marc Kikuchi, was testament to the core strengths in areas of research and development and intellectual property.
You have reached your limit for free articles this month.
Register to The Hindu for free and get unlimited access for 30 days.
Subscription Benefits Include
Today’s Paper
Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Not convinced? Know why you should pay for news.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
[ad_2]
Source link